Binding Selectivity Studies of Phosphoinositide 3-Kinases Using Free Energy Calculations-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Binding Selectivity Studies of Phosphoinositide 3-Kinases Using Free Energy Calculations

Published:2012-11-30 Issue:12 Volume:52 Page:3213-3224
ISSN:1549-9596
Container-title:Journal of Chemical Information and Modeling
language:en
Short-container-title:J. Chem. Inf. Model.

Author:

Sabbah Dima A.¹,Vennerstrom Jonathan L.¹,Zhong Haizhen A.²

Affiliation:

1. College of Pharmacy, University of Nebraska Medical Center, 986025 Nebraska Medical Center, Omaha, Nebraska 68198-6025, United States

2. DSC 362, Department of Chemistry, The University of Nebraska, 6001 Dodge Street, Omaha, Nebraska 68182, United States

Publisher

American Chemical Society (ACS)

Subject

Library and Information Sciences,Computer Science Applications,General Chemical Engineering,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/ci3003057

Reference47 articles.

1. The phosphatidylinositol 3-Kinase–AKT pathway in human cancer

2. Dual Inhibitors of PI3K/mTOR or mTOR-Selective Inhibitors: Which Way Shall We Go?

3. PI3Kγ inhibition: towards an 'aspirin of the 21st century'?

4. High Frequency of Mutations of the PIK3CA Gene in Human Cancers

5. Targeting the phosphoinositide 3-kinase pathway in cancer

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular mechanism elucidation of Ocimum basilicum as anticancer using system bioinformatic approach supported by in vitro assay;Pharmacia;2024-07-15

2. Selectivity Studies and Free Energy Calculations of AKT Inhibitors;Molecules;2024-03-10

3. Targeting the PI3K/AKT signaling pathway in anticancer research: a recent update on inhibitor design and clinical trials (2020–2023);Expert Opinion on Therapeutic Patents;2024-03-03

4. Binding and selectivity studies of phosphatidylinositol 3-kinase (PI3K) inhibitors;Journal of Molecular Graphics and Modelling;2023-06

5. Novel Derivatives of 4,6‐Dihydroxy‐2‐Quinolone‐3‐Carboxamides as Potential PI3Kα Inhibitors;ChemistrySelect;2022-08-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3